
Sign up to save your podcasts
Or


Are statins as risky as labels suggest? 📊
In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations.
No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury.
Absolute excess risks were tiny (
Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡
By Dr RR Baliga, MD, MBA5
66 ratings
Are statins as risky as labels suggest? 📊
In a 154,664-patient individual-participant meta-analysis of 23 double-blind RCTs, only 4 of 66 listed adverse effects were confirmed — mainly small, dose-related liver enzyme elevations.
No causal signal for cognitive decline, depression, sleep disturbance, neuropathy, or kidney injury.
Absolute excess risks were tiny (
Cardiovascular benefit still overwhelmingly outweighs risk. Evidence matters. 💡

906 Listeners

3,374 Listeners

20,222 Listeners